COVID-19: Inequality and the pandemic

When confronted with the pandemic, we are anything but equals.

The end of drugs?

In mid-April 2014, the words 'scandal', 'secret', 'drugs', and 'Roche' (the Swiss drug giant) delighted the medical press, which was quick to publish tantalizing news about the ineffectiveness of Tamiflu and the enormous amounts spent by governments in order to stock up on the drug, in preparation for possible flu epidemics.

COVID-19: Excerpt from a diary on the Great Britain front

Noemina is a graduate of the University of Hertfordshire, UK, where she majored in health care. She is working in her field as of 2012. The journal excerpt she sent to us reflects her week-long experience at the epicentre of the battle with the new coronavirus in the intensive care unit, where serious cases are admitted.

COVID-19: How has it affected young people?

Early reports out of China showed that elderly people and the chronically ill were most vulnerable to Covid-19. Yet an alarming number of young people in the United States have been hospitalized with severe infections. According to the Centers for Disease Control and Prevention, nearly 40% of American Covid-19 patients who were hospitalized were under 55 – and 20% were between ages 20...

COVID-19: Those who “would have died anyway”. How much is a human life worth?

Discussions about the reasonable number of deaths in a pandemic, about whether or not the price for saving people is killing the economy and, ultimately, debates on a life’s value were brought to the fore by the COVID-19 pandemic.